Puromycin aminonucleoside modulates p130Cas of podocytes

Tae-Sun Ha1, Ji-Young Choi, Hye-Young Park

  • 1Department of Pediatrics, Chungbuk National University College of Medicine, Cheongju, Korea. ; Postgraduate School, Chungbuk National University College of Medicine, Cheongju, Korea.

Abstract

Insights

Puromycin aminonucleoside (PAN) damages podocytes, altering p130Cas protein expression and distribution. Antioxidants like EGCG and vitamin C reversed these PAN-induced changes, suggesting a role for oxidative stress in podocyte dysfunction.

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Biology

Background:

  • Puromycin aminonucleoside (PAN) induces podocyte injury, characterized by foot process effacement and altered protein localization.
  • p130Cas is a crucial docking protein linking the actin cytoskeleton to the glomerular basement membrane in podocytes.

Purpose of the Study:

  • To investigate alterations in p130Cas expression and distribution within podocytes following PAN-induced injury in vitro.
  • To assess the potential protective effects of antioxidants against PAN-induced changes in p130Cas.

Main Methods:

  • Cultured rat glomerular epithelial cells and mouse podocytes were treated with PAN and various antioxidants (probucol, EGCG, vitamin C).
  • Changes in p130Cas expression were analyzed using confocal immunofluorescence, Western blotting, and RT-PCR.

Main Results:

  • PAN administration caused dose-dependent internalization and altered distribution of p130Cas in podocytes.
  • PAN decreased p130Cas protein and mRNA levels, effects reversed by EGCG and vitamin C.
  • p130Cas colocalized with P-cadherin, and its distribution shifted from diffuse to granular upon PAN treatment.

Conclusions:

  • PAN induces quantitative and distributional changes in podocyte p130Cas, likely mediated by oxidative stress.
  • Antioxidants demonstrate a protective effect, restoring normal p130Cas expression and distribution.
  • These findings highlight the role of p130Cas in PAN-induced podocyte dysfunction and suggest therapeutic potential for antioxidants.

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...